Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    PR Mobile Headlines    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory    |    Private Branding
All Press Releases for February 14, 2008 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Osteoarthritis: MAGCELL ARTHRO New Effective Treatment in the UK
PHYSIOMED ELEKTROMEDIZIN AG leading German manufacturers of high quality physical therapy equipment, have just released details of their new patented and clinically proven device MAGCELL ARTHRO, which is now available from their UK distributor PhysioPod UK Limited. 
x-small text small text medium text large text


    /24-7PressRelease/ - NOTTINGHAM, UK, February 14, 2008 - MAGCELL ARTHRO is an electrode free electrotherapy device for Osteoarthritis sufferers that can be used for self-treatment. The high-dose magnetic pulse fields can travel through clothes and shoes and deep into the tissue (without side affects) to the affected joint area and thus directly into the pain centre; inducing therapeutically effective, electrical fields (3-4cm depth). These fields work quickly on painful hip and knee arthritis, Hallux Rigidus (disorder of the joint located at the base of the big toe causing pain and stiffness) and bunions; as well as other arthrotic conditions; immediately soothing inflammation, improving cellular metabolism and increasing mobility.
MAGCELL ARTHRO has been developed for acute and long-term relief of Arthrosis. It is easy to apply via a one button system of operation that provides immediate results for the sufferer. A treatment is 2 x two-and-a-half minute sessions daily, just switch on and begin; it automatically shuts off after a treatment. Portable and handy-sized, it is fitted with AA batteries and comes with a metal storage container. See extract from one Magcell user below:
"I have had to deal with pain in my elbow and knee for many years. The pain was particularly bad in the morning. Over time, movement became increasingly limited, putting a strain on my daily life. I was initially treated with injections, which helped but only for a certain period of time. Then the pain and joint stiffness would return. Then I tested MAGCELL ARTHRO: I treated the elbows and knees twice daily. In just two days I noted a significant improvement. Within a week, I had no more pain".
Clinical study results (N.A. Hitrov & V.V. Portnov 2007), FAQ and Therapy Information can be viewed at http://www.soothe-joint-pain.com.

Media Contact Information Dr. Oliver Göhl PHYSIOMED ELEKTROMEDIZIN AG
E-MAIL oliver.goehl@physiomed.de PHONE +49 (0) 91 26 / 25 87-48
WEB http://www.physiomed.de

For UK Distribution PHYSIOPOD UK LIMITED
E-MAIL info@physiopod.co.uk PHONE 0115 9167 385

About PhysioPod UK Limited
PhysioPod UK Limited is the Sole UK distributor of the German patented therapy Deep Oscillation, for human and equine injuries. We have regular testimonials and endorsements of this unique therapy from it's high profile users and want to release these stories to the media. Please contact us at info@physiopod.co.uk 0115 9167 685 for further information.

# # #


Read more Press Releases from Mary Fickling:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Mary Fickling
PhysioPod UK Limited

Director
18 Heathcoat Street
Nottingham
England NG1 3AA
Voice: 0115 9167 685
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.